From the Journals

Omadacycline for Pediatric CAP

Case details intravenous-to-oral strategy after multiple antibiotic hypersensitivity reactions

Share

  • 1

    4-year-old girl with pneumonia and antibiotic hypersensitivities treated with omadacycline.

  • 2

    Symptoms included fever and productive cough.

  • 3

    Initial culture identified resistant Streptococcus pneumoniae and Mycoplasma pneumoniae.

  • 4

    Treatment included 7 days of intravenous omadacycline followed by oral doxycycline.

  • 5

    No hypersensitivity reactions during omadacycline therapy.

  • 6

    Follow-up showed regression of lung consolidation.

  • 7

    Call for prospective studies to evaluate omadacycline's efficacy in pediatrics.

Original Source(s)

Omadacycline for Pediatric CAP

Case details intravenous-to-oral strategy after multiple antibiotic hypersensitivity reactions

  • by Doug Brunk

  • February 16, 2026

  • 4 min

Related Content

When Constipation Signals Something More

Coordinated clinical and public health response supports timely identification and recovery of infant botulism.

IVF Babies and Allergy Risk: New Data

Cohort study of nearly 70,000 patients finds modest but statistically significant associations between assisted reproduction and asthma, allergic rhinitis, and atopic dermatitis

Vaccine Playbook Rewrite: Who’s In Charge?

HHS Secretary Robert F. Kennedy Jr.’s changes at the CDC are prompting states and medical societies to issue independent vaccine recommendations, challenging long-standing national immunization policy.